Literature DB >> 7620915

Amphetamine enhances memory retention and facilitates norepinephrine release from the hippocampus in rats.

E H Lee1, Y L Ma.   

Abstract

The present study investigated the effects of intrahippocampal amphetamine on memory retention and the role of hippocampal norepinephrine (NE) in memory consolidation in rats. One-way inhibitory avoidance learning paradigm was adopted. Animals were trained to avoid the foot shock. The latency to step into the shock compartment was recorded as the retention measure. The ceiling score (full retention) was 600 s. Results indicated that intra-hippocampal injections of amphetamine produced a dose-dependent enhancement of memory retention with doses at 0.6 micrograms and 1.6 micrograms reaching a significant effect. The beta-adrenergic blocker propranolol, at a dose which did not affect retention alone (80 ng), antagonized the memory-enhancing effect of amphetamine. Along with this memory-enhancing effect, amphetamine also elevated the level of NE release, and this effect was significant in animals not showing a full retention score (nonresponders) than in animals showing a full retention score (responders), as assayed by in vivo microdialysis. Within the control group, the responders also had a higher level of NE than the nonresponders. All these results are probably due to the fact that responders have a higher level of NE release than nonresponders. The effect of amphetamine on NE release is, therefore, not as obvious in responders. These results together support our hypothesis that NE plays a facilitatory role in the memory process and amphetamine enhances retention performance, at least in part, through facilitation of hippocampal NE release.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7620915     DOI: 10.1016/0361-9230(95)00039-9

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  16 in total

1.  Post-training, but not post-reactivation, administration of amphetamine and anisomycin modulates Pavlovian conditioned approach.

Authors:  Cory A Blaiss; Patricia H Janak
Journal:  Neurobiol Learn Mem       Date:  2007-01-26       Impact factor: 2.877

2.  Cognitive enhancement: methods, ethics, regulatory challenges.

Authors:  Nick Bostrom; Anders Sandberg
Journal:  Sci Eng Ethics       Date:  2009-06-19       Impact factor: 3.525

3.  Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice.

Authors:  Francesca Managò; Sebastien Lopez; Alberto Oliverio; Marianne Amalric; Andrea Mele; Elvira De Leonibus
Journal:  Psychopharmacology (Berl)       Date:  2012-11-29       Impact factor: 4.530

4.  Expression of integrin-associated protein gene associated with memory formation in rats.

Authors:  A M Huang; H L Wang; Y P Tang; E H Lee
Journal:  J Neurosci       Date:  1998-06-01       Impact factor: 6.167

5.  α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.

Authors:  Layla Azam; Uwe Maskos; Jean-Pierre Changeux; Cheryl D Dowell; Sean Christensen; Mariella De Biasi; J Michael McIntosh
Journal:  FASEB J       Date:  2010-08-25       Impact factor: 5.191

6.  Persistent expression of methamphetamine-induced CTA in periadolescent rats.

Authors:  Steven B Harrod; Ryan T Lacy; Lauren E Ballina
Journal:  Pharmacol Biochem Behav       Date:  2010-07-23       Impact factor: 3.533

7.  Pre-encoding administration of amphetamine or THC preferentially modulates emotional memory in humans.

Authors:  Michael E Ballard; David A Gallo; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2012-12-09       Impact factor: 4.530

8.  Nicotinic receptor-evoked hippocampal norepinephrine release is highly sensitive to inhibition by isoflurane.

Authors:  R I Westphalen; R S Gomez; H C Hemmings
Journal:  Br J Anaesth       Date:  2009-02-02       Impact factor: 9.166

9.  Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.

Authors:  Sarah A Morrow; Audrey Smerbeck; Kara Patrick; Diane Cookfair; Bianca Weinstock-Guttman; Ralph H B Benedict
Journal:  J Neurol       Date:  2012-09-23       Impact factor: 4.849

10.  The effects of L-amphetamine sulfate on cognition in MS patients: results of a randomized controlled trial.

Authors:  Sarah A Morrow; Tanya Kaushik; Peter Zarevics; David Erlanger; Mark F Bear; Frederick E Munschauer; Ralph H B Benedict
Journal:  J Neurol       Date:  2009-03-05       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.